Hassan Mushtaq

Mr. Hassan Mushtaq

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YZYusra Zarlashat
Yusra Zarlashat
Hassan MushtaqHassan Mushtaq
Hassan Mushtaq
LPLinh Pham
Linh Pham
WAWasim Abbas
Wasim Abbas
KSKeisaku Sato
Keisaku Sato
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and a significant global health burden, with increasing incidence rates and limited treatment options. Immunotherapy has become a promising approach due to its ability to affect the immune microenvironment and promote antitumor responses. The immune microenvironment performs an essential role in both the progression and the development of HCC, with different characteristics based on specific immune cells and etiological factors. Immune checkpoint inhibitors, including programmed death-1/programmed death-ligand 1 inhibitors (pembrolizumab, nivolumab, and durvalumab) and cytotoxic T lymphocyte antigen-4 inhibitors (tremelimumab and ipilimumab), have the potential to treat advanced HCC and overcome adverse effects, such as liver failure and chemoresistance. Phase II and phase III clinical trials highlight the efficacy of pembrolizumab and nivolumab, respectively, in advanced HCC patients, as demonstrated by their positive effects on overall survival and progression-free survival. Tremelimumab has exhibited modest response rates, though it does possess antiviral activity. Thus, it is still being investigated in ongoing clinical trials. Combination therapies with multiple drugs have demonstrated potential benefits in terms of survival and tumor response rates, improving patient outcomes compared to monotherapy, especially for advanced-stage HCC. This review addresses the clinical trials of immunotherapies for early-, intermediate-, and advanced-stage HCC. Additionally, it highlights how combination therapy can significantly enhance overall survival, progression-free survival, and objective response rate in advanced-stage HCC, where treatment options are limited.

27 March 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Hassan MushtaqHassan Mushtaq
Hassan Mushtaq
SSSyed Salman Shah
Syed Salman Shah
YZYusra Zarlashat
Yusra Zarlashat
MIMazhar Iqbal
Mazhar Iqbal
WAWasim Abbas
Wasim Abbas
The foot-and-mouth disease virus is a highly contagious and economically devastating virus of cloven-hooved animals, including cattle, buffalo, sheep, and goats, causing reduced animal productivity and posing international trade restrictions. For decades, chemically inactivated vaccines have been serving as the most effective strategy for the management of foot-and-mouth disease. Inactivated vaccines are commercially produced in cell culture systems, which require successful propagation and adaptation of field isolates, demanding a high cost and laborious time. Cell culture adaptation is chiefly indebted to amino acid substitutions in surface-exposed capsid proteins, altering the necessity of RGD-dependent receptors to heparan sulfate macromolecules for virus binding. Several amino acid substations in VP1, VP2, and VP3 capsid proteins of FMDV, both at structural and functional levels, have been characterized previously. This literature review combines frequently reported amino acid substitutions in virus capsid proteins, their critical roles in virus adaptation, and functional characterization of the substitutions. Furthermore, this data can facilitate molecular virologists to develop new vaccine strains against the foot-and-mouth disease virus, revolutionizing vaccinology via reverse genetic engineering and synthetic biology.

1 April 2019 in Chest
Verified
Journal Article
Closed access
MPM. Pervez
M. Pervez
SHS. Hashmi
S. Hashmi
AAA. Aahil
A. Aahil
AMA. Manji
A. Manji
Hassan MushtaqHassan Mushtaq
Hassan Mushtaq
SFS. Fatimi
S. Fatimi

30 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MSMuhammad Shaheryar
Muhammad Shaheryar
ARAbdul Rauf
Abdul Rauf
MAMuddassir Ali
Muddassir Ali
Hassan MushtaqHassan Mushtaq
Hassan Mushtaq
FAFurqan Awan
Furqan Awan
Rabies remains a persistently fatal zoonotic disease in Pakistan, where dog bites account for approximately 98% of human exposures. It is not a notifiable disease and results in severe epidemiological under-reporting. This Knowledge, Attitude, and Practice (KAP) study is the first to cross sectionally visualize the all ten administrative zones of Lahore which is Pakistan's second-most populous city. This study assessed rabies awareness and stray dog management practices among 243 respondents comprising pet owners (n=206, 85%) and veterinary professionals (n=37, 15%). A structured 30-item questionnaire was constituted covering three domains: knowledge (11 dichotomous items), attitude (10 Likert-scale items), and practice (9 multi-scale items). Non-parametric statistical analyses including Mann-Whitney U, Kruskal-Wallis with Dunn's post-hoc correction, Pearson's Chi-square, and Spearman's rank correlation were applied following confirmed non-normality by Shapiro-Wilk testing. Results revealed that 80.2% of respondents demonstrated low knowledge, 83.9% exhibited positive attitudes, and 81.5% demonstrated poor practices. Thus, a pronounced KAP gap was confirmed by a significant negative Spearman correlation between attitude and practice scores (ρ = −0.322, p < 0.001). Stakeholder type was a strong determinant of knowledge (p < 0.001), while age group significantly influenced both attitude (p = 0.002) and practices (p = 0.001). Gender could exert no significant influence across any KAP domain. Marked spatial disparities were observed across zones, with Data Ganj Baksh recording the highest knowledge prevalence (47%) versus Allama Iqbal Zone (9%). Choropleth mapping revealed that zones with relatively higher knowledge proportions did not correspond to better practice scores. These findings draw attention for the urgent need for a One Health-driven intervention strategy integrating community education, accessible post-exposure prophylaxis, and sustained mass dog vaccination to advance Pakistan's commitment to zero dog-mediated rabies deaths by 2030.